Brian S Sorg
Overview
Explore the profile of Brian S Sorg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
780
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sorg B, Byun J, Westbrook V, Tricoli J, Doroshow J, Harris L
J Natl Cancer Inst
. 2024 Aug;
116(12):1890-1895.
PMID: 39087596
Detection of cell-free circulating tumor DNA (ctDNA) from solid tumors is a fast-evolving field with significant potential for improving patient treatment outcomes. The spectrum of applications for ctDNA assays is...
2.
Ossandon M, Sorg B, Phatak D, Kalpakis K
Methods Mol Biol
. 2021 Nov;
2393:179-206.
PMID: 34837180
Tumor development can be indirectly evaluated using features of the tumor microenvironment (TME), such as hemoglobin saturation (HbSat), blood vessel dilation, and formation of new vessels. High values of HbSat...
3.
Sun C, Wu L, Wankhede M, Wang D, Thoerner J, Woody L, et al.
JCI Insight
. 2019 Apr;
4(7).
PMID: 30944254
Hypoxic tumor niches are chief causes of treatment resistance and tumor recurrence. Sickle erythrocytes' (SSRBCs') intrinsic oxygen-sensing functionality empowers them to access such hypoxic niches wherein they form microaggregates that...
4.
Ossandon M, Agrawal L, Bernhard E, Conley B, Dey S, Divi R, et al.
J Natl Cancer Inst
. 2018 Jun;
110(9):929-934.
PMID: 29931312
The importance of circulating free DNA (cfDNA) in cancer clinical research was recognized in 1994 when a mutated RAS gene fragment was detected in a patient's blood sample. Up to...
5.
Pearlman P, Divi R, Gwede M, Tandon P, Sorg B, Ossandon M, et al.
IEEE J Transl Eng Health Med
. 2016 Oct;
4:2800708.
PMID: 27730015
Point-of-care (POC) technologies have proved valuable in cancer detection, diagnosis, monitoring, and treatment in the developed world, and have shown promise in low-and-middle-income countries (LMIC) as well. Despite this promise,...
6.
Ghassemi P, Wang J, Melchiorri A, Ramella-Roman J, Mathews S, Coburn J, et al.
J Biomed Opt
. 2015 Dec;
20(12):121312.
PMID: 26662064
The emerging technique of rapid prototyping with three-dimensional (3-D) printers provides a simple yet revolutionary method for fabricating objects with arbitrary geometry. The use of 3-D printing for generating morphologically...
7.
Ossandon M, Phatak D, Sorg B, Kalpakis K
J Med Imaging (Bellingham)
. 2015 Jul;
1(1):014503.
PMID: 26158025
Features of the tumor microenvironment (TME), such as hemoglobin saturation (HbSat), can provide valuable information on early development and progression of tumors. HbSat correlates with high metabolism and precedes the...
8.
Lee J, Kozikowski R, Sorg B
Microvasc Res
. 2014 Dec;
98:29-39.
PMID: 25500481
Abnormal or compromised microvascular function is a key component of various diseases. In vivo microscopy of microvessel function in preclinical models can be useful for the study of a disease...
9.
Biel N, Lee J, Sorg B, Siemann D
Vasc Cell
. 2014 Aug;
6:17.
PMID: 25101168
Background: Angiogenesis is an essential process during tumor development and growth. The murine dorsal skinfold window chamber model has been used for the study of both tumor microvasculature and other...
10.
Han C, Choe S, Kim Y, Acharya A, Keselowsky B, Sorg B, et al.
Angiogenesis
. 2014 Jun;
17(4):823-830.
PMID: 24957885
Arteriovenous malformation (AVM) refers to a vascular anomaly where arteries and veins are directly connected through a complex, tangled web of abnormal AV fistulae without a normal capillary network. Hereditary...